2818-66-8Nc1ccc2[nH]c(=S)[nH]c2c1BXDMTLVCACMNJO-UHFFFAOYSA-N2818-66-8DTXSID3062651CHEMBL1708656Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 46 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesCompounds with a benzimidazole structure, led by omeprazole, can inhibit the acid secretion of gastric parietal cells induced by any stimulus, thus inhibiting the final step of gastric acid being pumped from the parietal cells into the gastric lumen, and therefore have the best therapeutic effect. 5-Amino-2-mercaptobenzimidazole, as an important starting material or intermediate for this type of drug, has a huge market demand.
Loading…